Stem cell therapy in CBC Health (Ischemic Stroke Recovery Treatment)

CBC Health's regenerative treatment uses high-dose intravenous cord blood infusion and is internationally available. The clinic's therapy has been successful in treating patients of different ages and with various inflammatory and neurological conditions, such as:

• Cerebral palsy (CP);
• Stroke (ischemic or hemorrhagic);
• Spinal cord injury (SCI);
• Rheumatoid arthritis (RA);
• Autism spectrum disorder (ASD);
• Ulcerative colitis (UC);
• Chronic obstructive pulmonary disease (COPD).

Additionally, CBC Health treats the early stages of:

• Dementia;
• Alzheimer's disease;
• Multiple sclerosis (MS);
• Traumatic brain injury (TBI);
• Cerebellar ataxia;
• Epileptic encephalopathy.

The CBC team has 20 years of experience and applies only high-quality blood components. For optimal therapeutic results, an infusion requires a dose of 50 million cells per kilogram. Each infusion includes cord blood from 4 to 8 donors, sourced from CBC Health's cord blood bank, one of the largest and oldest in Europe. CBC Health is currently the only practice worldwide offering this therapy with such a high concentration of cell components per kilogram of body weight.

Cord blood infusion does not replace standard therapy, but as an additional method, it helps brain cells regenerate and improve patient thinking and movement. The sooner treatment starts, the better the result. Continuous improvement is noticeable within a few weeks after the infusion.

The treatment lasts 2-3 days and occurs in one of the center's state-of-the-art day clinics in Eindhoven, the Netherlands.